510(k) device
Renu Gel
Cytophil, Inc. · System, Vocal Cord Medialization (MIX, Class II) · First FDA decision Apr 6, 2015, newest Apr 6, 2015Head and neck cancer
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Renu Gel"
MAUDE reports
0
Brand "Renu Gel", since 2015
PubMed studies
2
Mentioning "Renu Gel"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Renu Gel
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Renu Gel510(k)
K150400 · Decided Apr 6, 2015 · 47 days after receipt
Device type: System, Vocal Cord Medialization (MIX) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Renu Gel", any status and sponsor, newest update first.
No registered device study names "Renu Gel".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Renu Gel", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MIX
34 reports: 6 malfunction, 28 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Renu Gel"[tiab]. The summary above synthesizes these.
- Vocal Fold Injection of Absorbable Materials: A Histologic Analysis With Clinical Ramifications.
Zeitels SM, Lombardo PJ, Chaves JL, et al. · Ann Otol Rhinol Laryngol · 2019
- Local Reaction Causing Airway Compromise Following Vocal Fold Injection Augmentation with Carboxymethylcellulose.
Paoletti M, West J, van der Woerd B · J Voice · 2025Case Reports
Other devices of this type
Also filed under product code MIX.
- Silk Voice (SMI-04)Sofregen Medical · 510(k) 2024
- Calcium Hydroxylapatite Vocal Fold ImplantCytophil, Inc. · 510(k) 2013
- Vf LiquigelCoapt Systems, Inc. · 510(k) 2009
- Vocalis and Vocalis SmCytophil, Inc. · 510(k) 2009
- Vocalis GelCytophil, Inc. · 510(k) 2009
- Modification to Vf Gel PlusCoapt Systems, Inc. · 510(k) 2008
- Vf Gel PlusCoapt Systems, Inc. · 510(k) 2008
- Radiesse Laryngeal ImplantBioform Medical, Inc. · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.